Descriptor English: | Glucagonoma | ||||||
Descriptor Spanish: |
Glucagonoma
| ||||||
Descriptor Portuguese: | Glucagonoma | ||||||
Descriptor French: | Glucagonome | ||||||
Entry term(s): |
Adenoma, alpha Cell Adenoma, alpha-Cell Adenomas, alpha-Cell Glucagonoma Syndrome Glucagonoma Syndromes Glucagonomas Syndrome, Glucagonoma Syndromes, Glucagonoma Tumor, alpha-Cell Tumors, alpha-Cell alpha Cell Tumor alpha-Cell Adenoma alpha-Cell Adenomas alpha-Cell Tumor alpha-Cell Tumors |
||||||
Tree number(s): |
C04.557.470.200.025.290.750 C04.588.274.761.500.249 C04.588.322.475.500.249 C06.301.761.500.249 C06.689.667.500.249 C19.344.421.500.249 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D005935 | ||||||
Scope note: | An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA. |
||||||
Annotation: | coordinate IM with PANCREATIC NEOPLASMS (IM); for glucagonoma syndrome, coordinate also with NECROLYTIC MIGRATORY ERYTHEMA |
||||||
Allowable Qualifiers: |
BL blood BS blood supply CF cerebrospinal fluid CH chemistry CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SC secondary SU surgery TH therapy UL ultrastructure UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Islet Cell Tumor (1966-1981) |
||||||
Public MeSH Note: | 91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981 |
||||||
Online Note: | search ISLET CELL TUMOR 1981 |
||||||
History Note: | 91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981 |
||||||
Related: |
Necrolytic Migratory Erythema
MeSH | ||||||
DeCS ID: | 6079 | ||||||
Unique ID: | D005935 | ||||||
NLM Classification: | WI 810 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1981/05/20 | ||||||
Revision Date: | 2012/07/03 |
-
-
DISEASES
Neoplasms [C04]Neoplasms -
DISEASES
Neoplasms [C04]Neoplasms -
DISEASES
Neoplasms [C04]Neoplasms
|
Glucagonoma
- Preferred
Concept UI |
M0009315 |
Scope note | An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA. |
Preferred term | Glucagonoma |
Entry term(s) |
Adenoma, alpha Cell Adenoma, alpha-Cell Adenomas, alpha-Cell Glucagonoma Syndrome Glucagonoma Syndromes Glucagonomas Syndrome, Glucagonoma Syndromes, Glucagonoma Tumor, alpha-Cell Tumors, alpha-Cell alpha Cell Tumor alpha-Cell Adenoma alpha-Cell Adenomas alpha-Cell Tumor alpha-Cell Tumors |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey